Table 2.
Indicators of the expression level of the studied markers in patients determined by the immunohistochemistry.
| Marker | Expression Level in Patients, n = 34, Average Value % | Expression Level in Controls, n = 7, Average Value % |
|---|---|---|
| IL-1β | Diffuse in the matrix: 13.06 ± 3.65 (around the vessels 79.24 ± 8.12) Chondrocytes clusters in the NP: 56.15 ± 24.40 |
Diffuse in the matrix: 1.17 ± 0.47 (around the vessels 4.18 ± 1.72) Chondrocytes in the NP: 16.43 ± 10.10 |
| IL-6 | Diffuse in the matrix: 16.33 ± 5.40 Chondrocytes clusters in the NP: 49.65 ± 21.41 |
Diffuse in the matrix: 3.93 ± 1.17 Chondrocytes in the NP: 29.86 ± 8.45 |
| IL-17 | Diffuse in the matrix: 14.15 ± 5.12 (around the vessels 51.89 ± 7.35) Chondrocytes clusters in the NP: 63.71 ± 21.12 |
Diffuse in the matrix: 0.57 ± 0.35 (around the vessels 3.51 ± 1.60) Chondrocytes in the NP: 8.71 ± 5.77 |
| VEGF-A | Diffuse in the matrix: 16.82 ± 5.70 Chondrocytes clusters in the NP: 74.68 ± 19.17 |
Diffuse in the matrix: 0.51 ± 0.12 Chondrocytes in the NP: 17.43 ± 7.74 |
| CD31 | Diffuse in the matrix: 19.71 ± 9.25 | Diffuse in the matrix: 0 |
Notes. IL—interleukin; VEGF-A—vascular endothelial growth factor A.